TGA Approves Oxford/AstraZeneca COVID-19 vaccine

Megan Reilly

The Therapeutic Goods Administration (TGA) has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine.

The Product Information, FAQs and information on labelling and batch testing are also available on the COVID-19 vaccines hub.

Information on COVID-19 vaccines and the priority rollout to aged care providers, workers and residents is available here. Further information on the COVID-19 vaccine rollout is also available on the Department of Health website.